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Abstract The recent introduction of highly pathogenic strains
of West Nile virus (WNV) into naïve populations in Europe,
Israel, and the USA has resulted in a marked increase in both the
number of reported cases and the severity of disease compared
to previous outbreaks. The impact of the increased virulence of
recently emerged strains of WNV is exacerbated by the fact that
antiviral therapies and vaccines are not currently available for
use in humans. A greater understanding of the viral and host
factors involved inWNV-mediated neuropathology is necessary
to facilitate the development of novel therapeutic approaches.
This review summarizes the current state of knowledge of the
role of the cell-intrinsic innate immune responses as well as the
cell-mediated innate and adaptive immune responses in promot-
ing the detection and clearance of WNV from the CNS.
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Re-emergence of WNV
West Nile virus (WNV) is a member of the Flaviviridae, which
are enveloped, positive-stranded RNA viruses. This family in-
cludes several globally important emerging arthropod-borne
viruses that cause neuroinvasive disease in humans such as
Japanese encephalitis virus, tick-borne encephalitis, and
WNV. Combined, these viruses are responsible for significant
morbidity and mortality worldwide. Prior to the 1990s, WNV
infections were typically asymptomatic or associated with a
mild febrile illness known as West Nile fever. However, recent
epidemics in Europe and North America have been associated
with higher rates of severe disease, including meningitis, en-
cephalitis, and acute flaccid paralysis. Since its introduction into
the USA in 1999, yearly outbreaks of WNV in the USA have
resulted in more than 15,000 reported cases with neurological
complications and >1,500 deaths, making WNV the leading
cause of mosquito-borne neuroinvasive disease in the USA
(http://www.cdc.gov/ncidod/dvbid/westnile/index.htm).
WNVentry into the CNS
Neuroinvasive viruses enter the CNS via three main routes: (1)
retrograde transport along axons, (2) spread from olfactory
neurons and (3) hematogenous dissemination. Experimental
evidence in animal models suggests that WNV can use all three
methods to gain access to the CNS, depending on the route of
infection (Diamond et al. 2003; Getts et al. 2008; Roe et al.
2012; Samuel et al. 2007; Wang et al. 2004). However, hema-
togenous spread is thought to be the primary route of WNV
entry into the brain during a natural infection. Entry via this
route requires WNV to cross the blood–brain barrier (BBB).
The mechanism by whichWNV circumvents the BBB remains
controversial. Induction of peripheral expression of the
proinflammatory cytokine TNFα was initially proposed to
facilitateWNVentry into the CNS by triggering the breakdown
of the BBB (Wang et al. 2004). However, in subsequent studies,
low levels of TNFα detected in the serum of WNV-infected
mice did not correlate with an increase in the permeability of the
BBB or WNVentry into the CNS (Daffis et al. 2008; Dai et al.
2008; Shrestha et al. 2008). In addition, treatment of mice with
neutralizing antibodies to TNFα enhanced susceptibility to
WNV infection, suggesting that TNFα plays a role in control-
ling WNV replication rather that promoting viral dissemination
(Shrestha et al. 2008). Moreover, WNV neuroinvasion in
BALB/c mice can occur without an increase in the permeability
of the BBB (Morrey et al. 2008). Taken together, these studies
suggest that disruption of the BBB is not the primary mecha-
nism by which WNV initially enters the CNS. Increasing
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evidence suggests that WNVentry into the CNS is a multistep
process employing different mechanism as the infection pro-
gresses. Several groups have demonstrated that WNVreplicates
in brain microvascular endothelial cells and traverses an in vitro
model of the BBB without compromising the integrity of the
monolayer (Hussmann et al. 2013; Verma et al. 2009),
suggesting that WNV may initially gain access to the CNS by
directly infecting brain endothelial cells and releasing low levels
of progeny virus from the abluminal surface. Alternatively,
WNV may enter the CNS via a Trojan-horse mechanism
through the diapedesis of an infected leukocyte (Bai et al.
2010; Dai et al. 2008). Circumstantial evidence suggests that
the host response within the CNS and/or the process of leuko-
cyte diapedesis itself contribute to the breakdown of the BBB
late in infection (Roe et al. 2012). Thus, allowing the
unrestricted entry of free virus and/or infected leukocytes into
the CNS and promoting a second round ofWNVdissemination.
WNV replication within the CNS
Within the CNS, intimate connections between neurons, as-
trocytes, and brain endothelial cells from the neurovascular
unit (NVU; Fig. 1), which functions to regulate blood flow,
the integrity of the BBB, and neuronal activity in response to
environmental changes (Iadecola 2004). Because of its inter-
connectedness, perturbation of the function of any component
within the NVU can have pathological effects on the other
members. Studies in humans and mice have demonstrated that
neurons are the primary cells targeted by WNV. However,
WNV-positive brain microvascular endothelial cells and as-
trocytes have been detected in birds and humans, respectively,
suggesting that these cells may serve as secondary targets
in vivo (Lopes et al. 2007; van Marle et al. 2007;
Wunschmann et al. 2004). In vitro studies conducted at both
low and high MOIs demonstrated that pathogenic strains of
WNV replicate within all three cell types, though replication
in astrocytes was the most restricted (Cheeran et al. 2005;
Diniz et al. 2006; Hussmann et al. 2013; vanMarle et al. 2007;
Verma et al. 2010).
Animal studies using intracranial inoculation indicate that
most, if not all, strains of WNV can replicate within the CNS;
nonetheless, the extent of neurovirulence is strain-dependent
(Beasley et al. 2002; Shrestha et al. 2008). Recent studies have
begun to define the host determinants for susceptibility to
WNV in the various cell types comprising the NVU and the
viral factors responsible for the strain-dependent differences in
neuropathogenicity (Beasley et al. 2004; Beasley et al. 2005;
Cho et al. 2013; Hussmann et al. 2013; Shirato et al. 2004b).
Examination of WNV replication within the cells types com-
prising the NVU infected at low MOIs demonstrated that high
and low neuropathogenic strains ofWNVreplicate with similar
kinetics and to equivalent levels in brain microvascular endo-
thelial cells and neurons (Hussmann et al. 2013). However,
astrocytes exhibited a reduced susceptibility to the low
neuropathogenic strain compared to the high neuropathogenic
strain, suggesting a possible role for this cell type in limiting
WNV replication within the CNS.
Neuroimmune response to WNV
Similar to peripheral tissues, the immune response within the
CNS has both cell-intrinsic and cell-extrinsic components.
However, the non-renewable nature of neurons necessitates
the tight control of these responses to limit the possibility of
irreversible immune-mediated neuronal destruction. Indeed,
targeted disruption of various components of the immune
system indicates that both branches of the immune response
contribute to neuroprotection and neurodestruction during
WNV infection depending on the context.
Cell-intrinsic response to WNV within the NVU
The cell-intrinsic innate antiviral immune response is a first line
of defense against invading viral pathogens. It consists of
multiple antiviral programs that work in concert to control viral
replication and spread as well as promoting the cell-mediated
innate and adaptive immune responses. The proper and con-
trolled induction of this arm of the immune response is medi-
ated by specialized cellular proteins termed pattern-recognition
receptors (PRRs), which recognize specific pathogen-
associated molecular patterns (PAMPs) produced during the
course of infection (Fig. 2) (Janeway and Medzhitov 2002).
Two classes of PRRs, Toll-like receptors (TLRs) and RIG-I-like
receptors (RLRs), are involved in detecting WNV infection
(Daffis et al. 2008; Suthar et al. 2013; Suthar et al. 2010;
Town et al. 2009;Wang et al. 2004). TLRs are an evolutionarily
conserved family of transmembrane molecules that are
expressed on the cell surface or within endocytic vesicles and




Fig. 1 Neurovascular unit. Schematic of the composition of the
neurovascular unit
114 J. Neurovirol. (2014) 20:113–121
and endosomes. TLR expression is typically restricted to im-
mune cells, although expression is upregulated in many cell
types in response to invading pathogens. In contrast, the RLR
family members, RIG-I, MDA5, and LGP2, are cytoplasmic
RNA helicases that are basally expressed at low levels in most
cell types throughout the body. Upon detection of an invading
viral pathogen, PRRs initiate signaling cascades that activate a
number of latent transcription factors, such as IRF-3, IRF-7,
and NFκB. Activation of these transcription factors results in
the direct induction of antiviral effector proteins as well as
proinflammatory cytokines and chemokines. The antiviral ef-
fector proteins function to control viral replication within an
infected cell, while proinflammatory cytokines and chemokines
amplify the cell-intrinsic antiviral programs and shape the
nature of the cell-mediated immune responses. Recently, the
NOD-like receptor (NLR) NLRP3 was shown to contribute to
the cell-intrinsic response to WNVas well (Ramos et al. 2012);
though, it remains to be determined whether NLRP3 plays a
direct role in sensingWNVor an indirect role as a modulator of
either the TLR or RLR pathways (Davis et al. 2011). NLRP3
functions as part of a large multicomponent protein complex
termed the inflammasome, which serves as a molecular plat-
form for the activation of the inflammatory caspase, Caspase 1
(Davis et al. 2011; Kanneganti 2010). Activated Caspase 1
cleaves pro-IL-1 and pro-IL-18 into biologically active forms
that participate in the direct antiviral control of the invading
pathogen and the regulation of the adaptive and inflammatory
responses.
Transgenic mice with targeted deficiencies have been used
to assess the contributions of the TLR, RLR, and NRL signal-
ing pathways to controlling WNV replication within the CNS.
Genetic depletion of TLR3, TLR7, or the receptor for IL-1β
(IL-1R) resulted in increased viral loads within the CNS and
enhanced susceptibility to lethal infection (Daffis et al. 2008;
Durrant et al. 2013; Ramos et al. 2012; Town et al. 2009;Wang
et al. 2004). Similar results were observed in mice deficient for
MyD88, the adaptor molecule for TLR7 and IL-1R, or MAVS,
a key downstream signaling molecule required for the RLR
signal transduction pathway (Suthar et al. 2010; Szretter et al.

























Fig. 2 Cell-intrinsic innate antiviral response. Schematic of the key
signaling pathways contributing to the innate antiviral response to
WNV. Abbreviations: retinoic acid-inducible (RIG-I)-like receptors
(RLRs); Toll-like receptor (TLRs); melanoma differentiation antigen 5
(MDA5); laboratory of genetics and physiology 2 (LGP2); nucleotide-
binding oligomerization domain (NOD)-like receptors (NLRs); NLR
family PYD-containing 3 (NLPR3); TIR-domain-containing adapter-
inducing interferon-β (TRIF); myeloid differentiation primary response
88 (MyD88); interferon stimulated genes (ISGs)
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the innate antiviral response to WNV within the CNS.
However, the hierarchy of the involvement of these PRRs
within the CNS remains to be determined and is likely to be
cell-type specific.
Ex vivo studies have been used to investigate the cell-
intrinsic innate antiviral response within neurons. Higher viral
titers were detected in cortical neurons isolated from mice
genetically deficient for TLR3 or MAVS, suggesting that both
the TLR and RLR pathways play a role in restricting WNV
replication within this cell type (Daffis et al. 2008; Suthar et al.
2010). Additionally, MAVS-dependent signaling was essen-
tial for the rapid and robust activation of innate antiviral pro-
grams and the induction of type I IFNs (Suthar et al. 2010).
Disruption of IL-1β signaling also enhancedWNVreplication
within cortical neurons, suggesting that the NLR signaling
pathway contributes to the antiviral response to WNV within
neurons (Ramos et al. 2012). In addition, pretreatment of
cortical neurons with IL-1β and IFN-β in combination sub-
stantially reduced WNV replication compared to either factor
alone, suggesting that IL-1β functions synergistically with the
type I IFNs. However, a separate study demonstrated that
neutralization of IL-1β reduced WNV-induced apoptosis in
a human neuroblastoma cell line (Kumar et al. 2010),
suggesting that IL1-β can have toxic effects on neurons as
well. Notably, a recent report comparing basal and WNV-
induced innate immune signatures of cortical neurons isolated
from the cerebral cortex and granule cell neurons isolated
from the cerebellum demonstrated that neuronal subtypes
have distinct innate immune responses (Cho et al. 2013).
This analysis demonstrated that differences in basal levels of
expression of key PRRs, transcription factors, and antiviral
effector proteins resulted in the induction of unique innate
immune profiles, which corresponded with the relative per-
missiveness of the two neuronal subtypes.
In contrast to neurons, the cell-intrinsic innate antiviral
response in the other cell types comprising the NVU has not
been extensively examined. Since the antiviral response
contributes to the strain-specific control of replication of
other neurotropic viruses (Daffis et al. 2011; Johnston et al.
2001; Ryman et al. 2000), our lab assessed whether the
differential induction of the innate antiviral response con-
tributed to the decreased susceptibility of astrocytes to a low
neuropathogenic strain of WNV. Examination of the induc-
tion profiles of a panel of antiviral effector proteins
(Fredericksen et al. 2004; Scherbik et al. 2006; Szretter
et al. 2011) indicated that the kinetics and amplitude of the
antiviral response to high and low neuropathogenic strains of
WNV was similar in astrocytes (Hussmann and
Fredericksen, unpublished observation). This suggests that
the reduced level of replication of the low neuropathogenic
strain of WNV within astrocytes was not due to the prefer-
ential induction of antiviral effector proteins. A detailed
analysis of WNV replication within astrocytes indicated that
the reduced susceptibility to low neuropathogenic strains
was due to a delay in the synthesis of the viral genome and
a reduction in the ability of this strain to spread from cell-to-
cell (Hussmann et al. 2013). The restriction to viral spread
was suggestive of the paracrine protection of type I IFNs and
indeed, measureable levels of type I IFN were detected in
supernatants recovered from cultures infected with either
strain. However, neutralization of type I IFNs did not en-
hance the ability of the nonneuropathogenic strain to spread
from cell-to-cell within the monolayer, suggesting that clas-
sical innate antiviral responses play only a modest role in
restricting WNV replication within astrocytes.
One of the strategies that WNV uses to circumvent the
cell-intrinsic antiviral host response is to evade detection by
RIG-I at early times post-infection, thereby postponing in-
duction of the response until after a productive infection has
been established (Fredericksen and Gale 2006; Fredericksen
et al. 2004). A similar delay in activation of the antiviral
response was observed in WNV-infected astrocytes, brain
endothelial cells, and neurons (Hussmann and Fredericksen,
unpublished observation). The mechanism(s) by which
WNV evades detect by RIG-I has yet to be determined.
However, a systematic analysis of the WNV viral genome
and antigenome identified multiple regions capable of rap-
idly activating RIG-I (Shipley et al. 2012). Yet, incorporation
of these stimulatory regions into larger RNAs abrogated their
capacity to rapidly activate RIG-I signaling, suggesting that
WNVevades detection by RIG-I at early times post-infection
by sequestering stimulatory RNA ligands within the intact
viral genome and antigenome. Nonetheless, the eventual
activation of the RIG-I pathway suggests that WNV
PAMPs become exposed to the cell’s antiviral sensors over
time. This unmasking of RIG-I-specific PAMPs buried with-
in the WNV genome and antigenome may be mediated by
the cell’s normal RNA processing pathways. Indeed, the
OAS/RNAseL pathway has been shown liberate a potent
RNA PAMP from the HCV genome (Malathi et al. 2007,
2010). Consistent with this model, larger nonstimulatory,
nonreplicating fragments of the WNV genome induced a
RIG-I-specific antiviral response over a longer time course
(Shipely and Fredericksen, unpublished observation).
Cell-mediated immunity
The restrictive nature of the BBB ensures that under normal
physiological conditions, the CNS is an immune-specialized
compartment with limited leukocyte infiltration. However,
WNV infection results in a multifocal, mixed leukocyte
neuroinflammatory response consisting of monocytes, neutro-
phils, natural killer (NK) cells, dendritic cells (DC) as well as
effector CD4+ and CD8+ Tcells (Brehin et al. 2008; Glass et al.
2005; Lim et al. 2011; Omalu et al. 2003; Shrestha et al. 2006;
Sitati et al. 2007). Leukocyte infiltration is critical for clearance
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ofWNV from the CNS and is one of the major determinants for
survival. CD8+ T cells in particular play a central role in the
clearance of highly neuropathogenic strains of WNV from the
CNS (Klein et al. 2005; Shrestha et al. 2006; Sitati et al. 2007).
Mice deficient for CD8+ T cells have higher viral loads within
the CNS and are more susceptible to a lethal infection with
WNV compared to immunocompetent mice (Shrestha et al.
2006). Similar results were observed in mice deficient for
CD4+ cells. However, further analysis indicated that CD4+ T
cells are necessary to sustain the CD8+ T cell response within
the CNS (Sitati and Diamond 2006), though CD4+ T cells may
play a direct role in controlling the WNV replication within the
periphery (Brien et al. 2008). Nevertheless, recruitment of
effector T cells to the CNS is not sufficient to clear WNV
infection. As discussed in later sections, T cells must be
recruited to the proper location within the CNS and undergo
additional stimulation in order to mediate viral clearance.
Monocytes, the most prevalent infiltrating cell type de-
tected in the brains of WNV-infected mice (Getts et al. 2012;
Glass et al. 2005), also play an important role in controlling
WNV infection. Severely monocytopenic mice exhibited
enhanced viral loads within the CNS and increased suscep-
tibility to lethal infect with WNV (Lim et al. 2011). Once
within the CNS, inflammatory monocytes differentiate into
macrophages and microglia (Getts et al. 2008). Increasing
evidence suggests that infiltrating monocyte-derived cells
and resident microglia are functionally non-redundant
(Shechter and Schwartz 2013). Therefore, these two cell
types are likely to perform different roles in controlling
WNV-mediated pathogenesis. A recent study suggests that
resident microglia play a protective role during WNV infec-
tion, limiting neuronal death and/or promoting CNS repair,
rather than contributing directly to the inhibition of viral
replication or the stimulation of WNV-specific T cells
(Wang et al. 2012b). The observation that mice deficient
for MHC II expression are unable to clear WNV from the
CNS underscores the importance of monocyte-derived
antigen-presenting cells (APCs) and/or DCs to the
neuroimmune response to WNV (Sitati and Diamond
2006). As with the peripheral immune response, APCs with-
in the CNS have the potential for a spectrum of activities
including the production and secretion of neurotropic fac-
tors, recruitment of T cells into the parenchyma of the brain
and the stimulation of effector T cells (Savarin et al. 2010;
Shechter and Schwartz 2013). While the precise role(s) of
monocyte-derived cells in controlling WNV replication and
spread within the CNS remains to be determined, a recent
report suggests that DCs contribute to the optimal activation
of effector T cells (Durrant et al. 2013).
Neutrophils are hypothesized to play a biphasic role during
WNV infection, enhancing viral spread to the CNS early in
infection and attenuating viral pathogenesis at later times (Bai
et al. 2010). Consistent with this model, depletion of
neutrophils prior to infection resulted in decreased viral loads
within the CNS and enhanced survival (Bai et al. 2010), while
depletion after WNV infection shortened survival times. The
ability of neutrophils to promote WNVentry into the CNS is
further supported by the observation that disruption of neu-
trophil migration decreased viral loads within the CNS,
lengthened survival times, and, in some circumstances, re-
duced susceptibility to a lethal infection (Bai et al. 2010;
Wang et al. 2012a).
While neuroinflammation is essential for constraining
WNV spread within the CNS and promoting viral clearance,
several studies suggest that this process can have immuno-
pathological consequences as well. Infection of CD8+ T cell-
deficient mice with attenuated strains of WNV resulted in
prolonged survival times and, depending on the viral dose
that was administered, enhanced survival compared to WT
mice (Szretter et al. 2012; Wang et al. 2003). Likewise,
delaying monocyte migration to the CNS prolonged survival
times and blocking migration decreased mortality in mice
challenged intranasally with a low neuropathgenic strain of
WNV (Getts et al. 2012, 2008). The effectiveness of the
neuroinflammatory response in controlling an invading path-
ogen depends on a variety of factors such as the recruitment
of immune cells to the appropriate location, at the right time
and at the correct dose and elimination of the immune cell
once the infection is cleared. The factors responsible for
tipping the neuroinflammatory response to WNV from
neuroprotective toward neuropathogenic are currently
unknown.
Neuroinflammation
Because the inappropriate recruitment or retention of im-
mune cells can have detrimental effects, the inflammatory
response is, by necessity, a highly regulated, multistep pro-
cess. This process is mediated in large part by the expression
of chemoattractant cytokines, known as chemokines, and
their cognate receptors on the targeted leukocyte. The first
phase of leukocyte recruitment to the CNS is the initial
attraction and movement of immune cells across the endo-
thelial layer and into perivascular spaces. Since soluble gra-
dients are rapidly dispersed by normal blood flow, the initial
recruitment of leukocytes across the endothelial layer is
mediated by solid phase gradients formed by chemokines
binding to anchored glycosaminoglycans or scavenger re-
ceptors on endothelial cell surfaces (Middleton et al. 2002).
Binding of immobilized chemokines to their cognate recep-
tors on leukocytes triggers the activation of integrins on the
surface of leukocytes, thereby promoting firm attachment to
the endothelial cell layer. Leukocyte migration across an
endothelial layer can occur via paracellular diapedesis,
which requires disassembly of intercellular junctions, or
transcellular diapedesis, which involves uptake and
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translocation through the endothelial cell itself (Carman
2009; Middleton et al. 2002). Due to the enhanced stability
of the inter-endothelial tight junctions, transcellular diapede-
sis is the primary route of leukocyte infiltration across an
intact BBB (Carman 2009; Greenwood et al. 1994; Wolburg
et al. 2005). Therefore, the infiltration process at the BBB
requires the establishment of a transcellular chemokine gra-
dient within endothelial cells to facilitate the directional
movement of immune cells into the perivascular space with-
in the CNS (Carman 2009; Middleton et al. 2002). Once
across the BBB, the chemokine profile within the
perivascular space determines whether the infiltrating im-
mune cells remain localized or migrate into the parenchyma
of the CNS (McCandless et al. 2008; Wilson et al. 2010).
Increased levels of several proinflammatory chemokines and
their cognate receptors have been detected in the brains of
WNV-infected mice (Fig. 3) (Glass et al. 2005; Klein et al.
2005; Lim et al. 2011; Shirato et al. 2004a). The role of several
of these factors in WNV-induced neuroinflammation has been
confirmed using transgenic mice with targeted deficiencies
(Glass et al. 2005; Klein et al. 2005; Lim et al. 2011; Zhang
et al. 2008). Genetic depletion of the chemokine receptor
CCR5, expressed on subsets of T lymphocytes, NK cells,
monocytes, and macrophages, impaired the trafficking of the
corresponding leukocytes to the CNS in response to WNV
infection (Glass et al. 2005; Lim et al. 2011). In addition, severe
monocytopenia in CCR2−/− mice resulted in a monocyte-
specific deficiency in the brains of WNV-infected animals
(Lim et al. 2011). However, genetic depletion of either
CXCL10 or its cognate receptor CXCR3 specifically abrogated
CD8+ Tcell migration to the cerebellum inWNV-infected mice
without disrupting migration into other parts of the brain (Klein
et al. 2005; Zhang et al. 2008). In all three cases, perturbation of
the neuroinflammatory response resulted in higher viral loads
and a marked increase in mortality, demonstrating the impor-
tance of regulated leukocyte infiltration in controlling WNV
infection in mice. Whether the neuroinflammatory response
plays a similar role in controlling disease in humans remains
to be determined; however, genetic evidence suggests that in-
dividuals lacking functional CCR5 are at an increased risk for
symptomatic infection with WNV (Glass et al. 2006; Lim et al.
2008; Lim et al. 2010).
Recent studies suggest that chemokine expression by the
different cell types within the CNS can have counterbalancing
effects on leukocyte localization within brains of WNV-
infected mice. Neuronal production of CXCL10 promotes T
cell migration into the parenchyma of the CNS (Klein et al.
2005; Zhang et al. 2008); however, the polarized expression of
CXCL12 at the basal lateral surface of the endothelial cells can
impede migration by retaining T cells in perivascular spaces
(McCandless et al. 2008). Normally, the restriction of leuko-
cytes to perivascular spaces within the CNS is a protective
measure that limits the neuropathological consequences of
immune cell infiltration. However, in the case of WNV, this
restriction is counterproductive to viral clearance and survival.
Indeed, McCandless et al. demonstrated that antagonism of
CXCR4, the receptor for CXCL12, enhanced intraparenchymal
migration of CD8+ T cells and resulted in decreased viral loads
within the CNS, reduced immunopathology and enhanced
survival (McCandless et al. 2008).
While chemokines control the recruitment and distribution
of immune cells within the CNS, cytokines play a central role in
regulating the activation of these cells. A recent study suggests
that the cytokine IL-1 plays an important, though indirect role,
in controlling the activation of effector T cells within the CNS
of WNV-infected mice (Durrant et al. 2013). Mice deficient for
IL-1 receptor (IL-1R1) exhibited enhanced susceptibility to
WNV infection compared to WT mice despite the fact that
CD8+ and CD4+ T cells were efficiently recruited to the paren-
chyma of the CNS. Ex vivo analysis of T cells recovered from
IL-1R1 deficient mice indicated that CD8+ Tcells were capable
of responding to WNV, but the effector function of CD4+ T
cells was impaired. However, the lack of IL1-R1 expression on
CD8+ or CD4+ T cells in WT mice suggested that IL-1 did not
directly act on either of these cell types. Further characterization
of immune cells within the CNS of WNV-infected IL-1R1−/−
mice demonstrated that IL-1 was required for the full activation
of DC-like APCs within the CNS. Moreover, adoptive transfer




















Fig. 3 Chemokines and chemokine receptors involved in the
neuroinflammatory response to WNV. Chemokines and the chemokine
receptors upregulated in the brains of WNV-infected mice
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WNV-infected IL-1R1−/− mice, confirming the requirement of
IL-1 responsive DCs for optimal activation of the effector Tcell
response during WNV neuroinvasion and demonstrating the
importance of professional APCs to the neuroimmune response
to WNV.
Conclusions
The dramatic increase in the number of WNV infections during
the most recent transmission season within the USA and the
outbreaks in Eastern Europe serve as a reminder that WNV is
likely to remain a public health concern in the coming years. It
is now clear that the neuroimmune response to WNV is a
dynamic, multifactorial process involving the cell-intrinsic im-
mune response as well as the cell-mediated innate and adaptive
responses. A more complete understanding of these immune
processes will be essential for the development of novel thera-
peutic agents for treating the severe neurological symptoms
associated with WNV infection. Experiments in mice suggest
that therapies modulating the neuroinflammatory can improve
the outcome of WNV infection (Getts et al. 2012; McCandless
et al. 2008). However, the dual nature of neuroinflammatory
responses will necessitate the development of highly directed
therapies capable of maximizing the neuroprotective effects of
infiltrating immune cells while minimizing the potential for
immunopathology.
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